While for miR-199a-2 promoter, the ∼50% of DNA methylation of normal brain DNA corresponded to a moderate REST binding of Chr1, whereas the hypomethylation of gliomas tissues corresponded to a very low degree of REST binding. Here, REST is linked to central nervous system cancer.